Global and China Obesity Treatment Industry Ecological Development and Analysis Report 2023

Report ID: ARS3092 | Category: Agriculture | Pages: 122 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3100.00 Multi User-$5600.00

Report Description
View Table of Contents

Report Summary

In terms of market side, this report researches the Obesity Treatment revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

The global Obesity Treatment market size in 2022 is 11630.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 16.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Obesity Treatment market include VIVUS Inc. (US), Arena Pharmaceuticals Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), and Allergan Plc (US). The share of the top 3 players in the Obesity Treatment market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Obesity Treatment market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Adjusting gastric Banding accounted for XX% of Obesity Treatment market in 2022. Roux-en-Y Gastric Bypass share of XX%.
Appetite suppressants accounted for XX% of the Obesity Treatment market in 2022. Combination drugs accounts for XX%.

Report Includes:
This report presents an overview of global market for Obesity Treatment. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Obesity Treatment, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Obesity Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Obesity Treatment market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Obesity Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Obesity Treatment sales, projected growth trends, technology, application and end-user industry.

Digital technology is becoming more and more popular in agricultural value chain
Digital technology is becoming more and more popular in agricultural value chain, which reduces information asymmetry, improves transparency and raises output to a new high. So far, agricultural technology has promoted the development of agriculture in four "times" and continues to determine the maturity of producing countries.
For example, in terms of corn production, Africa and India are still in the first stage, known as the Green Revolution, which is characterized by the use of fertilizers and pesticides. Argentina, Brazil and China are in the stage of modern agriculture, which involves a new generation of crop protection products and new farming methods, such as mechanization. The European Union and the United States have developed into the 21st century agriculture characterized by precision agriculture-for example, using advanced analytical techniques to apply nutrients and crop protection products in different proportions.
In the next few years, only the producers who master precision agriculture can be ready to use the fourth era, that is, the next generation of agricultural technology. Although it is still far away, this era will be characterized by the the proliferation of biotechnologies, gene editing (such as CRISPR), and automation, including agricultural robots that will monitor fields and harvest crops.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
VIVUS Inc. (US)
Arena Pharmaceuticals Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Novo Nordisk A/S (Denmark)
Allergan Plc (US)
Medtronic (US)
Ethicon (a subsidiary of Johnson & Johnson) (US)
Cousin Biotech (France)
EnteroMedics Inc. (US)
and USGI Medical Inc. (US).

Types list
Adjusting gastric Banding
Roux-en-Y Gastric Bypass
Sleeve gastrectomy
Biliopancreatic diversion with Duodenal Switch
Endoscopic Procedures

Application list
Appetite suppressants
Combination drugs
Malabsorption
Satiety drugs

Table of Content

1 Obesity Treatment Market Introduction and Overview
1.1 Obesity Treatment Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Obesity Treatment Revenue and Market Share by Manufacturer
2.2 Manufacturers Obesity Treatment Production Sites, Area Served, Product Types
2.3 Obesity Treatment Market Competitive Situation and Trends
2.3.1 Obesity Treatment Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Obesity Treatment Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Obesity Treatment Market Share by Type 2018 VS 2022
3.2 Global Obesity Treatment Revenue and Market Share by Type
4 Global Obesity Treatment Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Obesity Treatment Market Share by Application 2018 VS 2022
4.2 Global Obesity Treatment Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Obesity Treatment Market Size (2018-2023)
5.2 Obesity Treatment Growth Trends Analysis by Regions
5.2.1 Obesity Treatment Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Obesity Treatment Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Obesity Treatment Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Obesity Treatment Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Obesity Treatment Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Obesity Treatment Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1  VIVUS Inc. (US)
6.1.1 VIVUS Inc. (US) Company Profile
6.1.2 Obesity Treatment Product Overview
6.1.3 VIVUS Inc. (US) Obesity Treatment Market Performance (2018-2023)
6.1.4 VIVUS Inc. (US) Business Overview
6.1.5 SWOT Analysis
6.2  Arena Pharmaceuticals Inc. (US)
6.2.1 Arena Pharmaceuticals Inc. (US) Company Profile
6.2.2 Obesity Treatment Product Overview
6.2.3 Arena Pharmaceuticals Inc. (US) Obesity Treatment Market Performance (2018-2023)
6.2.4 Arena Pharmaceuticals Inc. (US) Business Overview
6.2.5 SWOT Analysis
6.3  F. Hoffmann-La Roche Ltd. (Switzerland)
6.3.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
6.3.2 Obesity Treatment Product Overview
6.3.3 F. Hoffmann-La Roche Ltd. (Switzerland) Obesity Treatment Market Performance (2018-2023)
6.3.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
6.3.5 SWOT Analysis
6.4  Novo Nordisk A/S (Denmark)
6.4.1 Novo Nordisk A/S (Denmark) Company Profile
6.4.2 Obesity Treatment Product Overview
6.4.3 Novo Nordisk A/S (Denmark) Obesity Treatment Market Performance (2018-2023)
6.4.4 Novo Nordisk A/S (Denmark) Business Overview
6.4.5 SWOT Analysis
6.5  Allergan Plc (US)
6.5.1 Allergan Plc (US) Company Profile
6.5.2 Obesity Treatment Product Overview
6.5.3 Allergan Plc (US) Obesity Treatment Market Performance (2018-2023)
6.5.4 Allergan Plc (US) Business Overview
6.5.5 SWOT Analysis
6.6  Medtronic (US)
6.6.1 Medtronic (US) Company Profile
6.6.2 Obesity Treatment Product Overview
6.6.3 Medtronic (US) Obesity Treatment Market Performance (2018-2023)
6.6.4 Medtronic (US) Business Overview
6.6.5 SWOT Analysis
6.7  Ethicon (a subsidiary of Johnson & Johnson) (US)
6.7.1 Ethicon (a subsidiary of Johnson & Johnson) (US) Company Profile
6.7.2 Obesity Treatment Product Overview
6.7.3 Ethicon (a subsidiary of Johnson & Johnson) (US) Obesity Treatment Market Performance (2018-2023)
6.7.4 Ethicon (a subsidiary of Johnson & Johnson) (US) Business Overview
6.7.5 SWOT Analysis
6.8  Cousin Biotech (France)
6.8.1 Cousin Biotech (France) Company Profile
6.8.2 Obesity Treatment Product Overview
6.8.3 Cousin Biotech (France) Obesity Treatment Market Performance (2018-2023)
6.8.4 Cousin Biotech (France) Business Overview
6.8.5 SWOT Analysis
6.9  EnteroMedics Inc. (US)
6.9.1 EnteroMedics Inc. (US) Company Profile
6.9.2 Obesity Treatment Product Overview
6.9.3 EnteroMedics Inc. (US) Obesity Treatment Market Performance (2018-2023)
6.9.4 EnteroMedics Inc. (US) Business Overview
6.9.5 SWOT Analysis
6.10  and USGI Medical Inc. (US).
6.10.1 and USGI Medical Inc. (US). Company Profile
6.10.2 Obesity Treatment Product Overview
6.10.3 and USGI Medical Inc. (US). Obesity Treatment Market Performance (2018-2023)
6.10.4 and USGI Medical Inc. (US). Business Overview
6.10.5 SWOT Analysis
7 Obesity Treatment Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Obesity Treatment Industrial Chain Analysis
8 Obesity Treatment Industry Dynamic Analysis
8.1 Obesity Treatment Market Trends Analysis
8.2 Obesity Treatment Market Drivers Analysis
8.3 Obesity Treatment Market Challenges Analysis
8.4 Obesity Treatment Market Restraints Analysis
9 Global Obesity Treatment Forecast Market Analysis by Type & Application
9.1 Global Obesity Treatment Revenue Market Forecast by Type (2023-2029)
9.2 Obesity Treatment Revenue Market Forecast by Application (2023-2029)
10 Global Obesity Treatment Forecast Market Analysis by Region
10.1 Obesity Treatment Revenue Market Forecast by Region (2023-2029)
10.2 North America Obesity Treatment Forecast Market Analysis
10.3 EMEA Obesity Treatment Forecast Market Analysis
10.4 China Obesity Treatment Forecast Market Analysis
10.5 Asia-Pacific Obesity Treatment Forecast Market Analysis
10.6 Latin America Obesity Treatment Forecast Market Analysis
11 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and China Obesity Treatment Industry Ecological Development and Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?